Epidemiology of visceral leishmaniasis in India

National Medical Journal of India

Volumn 12, Issue 2, 1999, Pages 62-68

  Bora, D ^a  

^a NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CHILD; FEMALE; HUMAN; INDIA; INFANT; MALE; PRESCHOOL CHILD; REVIEW; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INDIA; INFANT; LEISHMANIASIS, VISCERAL; MALE;

EID: 0033093302     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Control of the Leishmaniases. Report of a World Health Organization Expert Committee. World Health Organ Tech Rep Ser 1990;793:1-158.
2. Sivaramakrishnaiah K, Ramanatham R. Studies on the effect of climate on leishmaniasis in India. Indian J Med Res 1967;55:1159-72.
3. Thakur CP. Treatment of kala-azar in India. Natl Med J India 1992;5:203-5.
4. Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992;46:296-306.
5. Davidson RN, Croft SL. Recent advances in treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg 1993;87:130-1.
6. Thakur CP. Diminishing effectiveness of currently used drug in the treatment of kala-azar and amphotericin B in antimony and pentamidine resistant kala-azar. In: Proceedings of International Seminar on Current Trends in Leishmania Research. New Delhi:Council for Scientific and Industrial Research, 1993:234-62.
7. Berman JD. Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy, and future strategies. Rev Infect Dis 1998;10:560-86.
8. Sundar S. Murray HW. Gamma interferon in the treatment of kala-azar and other forms of leishmaniasis. J Assoc Physicians India 1995;43:348-50.
9. Life in the Twenty-firstcentury: A vision for all. World Health Report 1998. Geneva: World Health Organization, 1998:45.
10. Bridging the gap. World Health Report 1995. Geneva:World Health Organization, 1995.
11. World Bank. Investing in health. World Development Report 1993. New York:Oxford University Press, 1993.
12. Kamath S, Hakim A, Mehta PJ. Leishmania donovani - knocking the door. J Assoc Physicians India 1995;43:315-16.
13. Grover NK. Kala-azar - a resurgence. J Indian Med Assoc 1991;89:329-30.
14. Desjeux P. Human leishmaniases: Epidemiology and public health aspects. World Health Stat Q 1992;45:267-75.
15. Thakur CP, Sinha GP, Pandey AK, Barat D, Singh RK. Daily versus alternate day regimen of amphotericin B in the treatment of kala-azar: A randomized comparison. Bull World Health Organ 1994;72:931-6.
16. Tropical Disease Research Progress 1995-96. Thirteenth Programme Report. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR).
17. Ahasan HAMN, Chowdhury MAJ, Azhar MA, Rafiqueddin AKM, Azad KAK. Deaths in visceral leishmaniasis (kala-azar) during treatment. Med J Malaysia 1996;51:29-32.
18. World Bank. The state in a changing world. World Development Report 1997. Oxford:Oxford University Press, 1998.
19. Choudhury N, Saxena NBL. Visceral leishmaniasis in India - A brief review. J Commun Dis 1987;19:332-40.
20. Seaman J, Mercer AJ, Sondorp E. The epidemic of visceral leishmaniasis in Western Upper Nile, Southern Sudan: Course and impact from 1984 to 1994. Int J Epidemiol 1996;25:862-71.
21. Shiv L, Saxena NBL, Dhillon GPS (eds). Manual on visceral leishmaniasis (kala-azar) in India. New Delhi:National Malaria Eradication Programme, Ministry of Health and Family Welfare, Government of India, 1996.
22. Rao JS, Rehman SJ, Singh J, Singh SK. Kala-azar in Ballia district, Uttar Pradesh. J Commun Dis 1992;24:116-20.
23. Bora D, Jain DC, Dhariwal AC, Rao JS. Distribution of kala-azar cases treated in Delhi. J Commun Dis 1998;30:68-70.
24. Chandra J, Anand V, Patwari AK, Mandal RN, Aneja S, Sharma D. Kala-azar: Experience from a non-endemic area in India. J Trop Pediatr 1995;41:298-300.
25. Marwaha N, Sarode R, Gupta RK, Garewal G, Dash S. Clinico-hematological characteristics in patients with kala-azar: A study from north-west India. Trop Geogr Med 1991;43:357-62.
26. Aggarwal P, Wali JP. Profile of kala-azar in north India. Asia Pac J Public Health 1991;5:90-3.
27. Bryceson ADM. Leishmaniasis. In: Weatherall DJ, Ledingham JGG, Warrell DA (eds). Oxford textbook of medicine. Oxford:Oxford University Press, 1996: 899-907.
28. Sanyal RK, Banerjee DP, Ghosh TK, Ghosh JN, Misra BS, Roy YP, et al. A longitudinal review of kala-azar in Bihar. J Commun Dis 1979;11:149-69.
29. Addy M, Nandy A. Ten years of kala-azar in West Bengal, Part-I. Did post kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas? Bull World Health Organ 1992;70:341-6.
30. Hati AK. Visceral leishmaniasis in India - past and present (1989-1991). J Vivekanand Insititute Med Sci 1989-91;12-14:21-5.
31. Hati AK, Nandy A, Choudhury AB. An epidemic outbreak of kala-azar in a district of West Bengal, India. WHO/VBC/85 1995;911:1-9.
32. Acton HW, Napier LE. Post kala-azar dermal leishmaniasis. Indian J Med Res 1927;15:97-106.
33. Alam SN, Mukhopadhyaya AK. An epidemiological study on post kala-azar dermal leishmaniasis in parts of Bihar (India). Indian J Parasitol 1989;13:295-7.
34. Thakur CP, Kumar K. Efficacy of prolonged therapy with stibogluconate in post kala-azar dermal leishmaniasis. Indian J Med Res 1990;91:144-8.
35. Ramesh V, Misra RS, Saxena V, Mukherjee A. Post-kala-azar dermal leishmaniasis: A clinical and therapeutic study. Int J Dermatol 1993;32:272-5.
36. Ramesh V. Post kala-azar dermal leishmaniasis. Australasian J Dermatol 1993;34:35.
37. Nandy A, Addy M, Banerjee D, Guha SK, Maji AK, Saha AM. Laryngeal involvement during post kala-azar dermal leishmaniasis in India. Trop Med Int Health 1997;2: 371-3.
38. Napier LE. An epidemiological consideration of the transmission of kala-azar in India. Indian J Med Res 1925;14:219-65.
39. Napier LE, Dasgupta CR. An epidemiological investigation of kala-azar in rural areas in Bengal. Indian J Med Res 1931;19:295-341.
40. Ross VC. Report on the kala-azar survey in Patna city. Indian Med Gazette 1928;63:486-90.
41. Sanyal RK, Alam SN, Kaul SM, Wattal BL. Some observations on epidemiology of current outbreaks of kala-azar in Bihar. J Commun Dis 1979;11:170-82.
42. Thakur CP. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis). Trans R Soc Trop Med Hyg 1984; 78:391-8.
43. Basu D, Mallik KK. Changes in age incidence of kala-azar in India. Indian J Public Health 1995;39:24.
44. Thakur CP, Kumar K. Post kala-azar dermal leishmaniasis: A neglected aspect of the kala-azar control programmes. Ann Trop Med Parasitol 1992;86:355-9.
45. Manson-Bahr PEC, Apted FIC. Mansons's tropical diseases. London:ELBS and Baillier Tindall, 1982:93-115.
46. Davidson S. The principles and practices of medicine. Tropical disease supplement London:ELBS; 1968:2.
47. Dhiman RC, Sen AB. Epidemiology of kala-azar in rural Bihar (India), using village as a component of study. Indian J Med Res (A) 1991;93:153-60.
48. Saran R, Gupta AK, Sharma MC. Evidence of leishmania donovani infection in household members residing with visceral leishmaniasis patients. J Commun Dis 1992;24:242-4.
49. Sunderam RM. Vector surveillance, insecticide dosage, spray schedule, frequency and constraints thereof. In: Proceedings of workshop on entomological and vector control aspects of kala-azar, 1991. Delhi:National Institute of Communicable Diseases, 1993:39-40.
50. Mukhopadhyay AK, Hati AK, Chakraborty S, Saxena NBL. Effect of DDT on Phlebotomus sandflies in kala-azar endemic foci in West Bengal. J Commun Dis 1996;28:171-5.
51. Verghese T, Rehman SJ. Critical appraisal of dynamics of kala-azar transmission vis-a-vis control measures in India. In: Proceedings of workshop on entomological and vector control aspects of kala-azar, 1991. Delhi:National Institute of Communicable Diseases, 1993:43-61.
52. Kumar V, Kesari SK, Sinha NK, Palit A, Ranjan A, Kishore K, et al. Field trial of an ecological approach for the control of Phlebotomus argentipes using mud and lime plaster. Indian J Med Res (A) 1995;101:154-6.
53. Saxena NBL, Aggarwal V, Dhillon GPS, Sharma RS, Rao JS. Visceral leishmaniasis control in India through primary health care system - A successful experiment of district level planning. J Commun Dis 1996;28:122-8.
54. Thakur CP, Frances Sister, Therese Sister, Victoria Sister, Puspa Sister. A kala-azar control programme for remote tribal communities. World Health Forum 1994;15 (3):245-7.
55. Bora D, Singh J, Bhattacharjee J, Kureel VR, Singh S, Sharma RS. An estimate of kala-azar in 1991 in district Vaishali of Bihar. J Commun Dis 1994;24:120-2.
56. Sherlock IA. Ecological interactions of visceral leishmaniasis in the state of Bahia, Brazil. Mem Inst Oswaldo Cruz 1996;91:671-83.
57. Indian vector now said to resist DDT. Trop Dis Rep News 1991;37:1-2.
58. Mebrahtu Y, Lawyer P, Githure J, Were JB, Muigai R, Hendricks L, et al. Visceral leishmaniasis unresponsive to pentostam caused by Leishmania tropica in Kenya. Am J Trop Med Hyg 1989;41:289-94.
59. Ardehali S, Sadeghi-Hassanabadi A, Moaddeb A, Abdollahi B, Malek-Hosseini Z, Evans DA. The characterization of leishmania from patients with lymphadenopathy in Shiraz, Iran. Trans R Soc Trop Med Hyg 1995;89:370-1.
60. NandyA, Addy M, Guha SK, Maji AK, Chaudhuri D, Chatterjee P. Co-existent kala-azar and malaria in India. Trans R Soc Trop Med Hyg 1995;89:516.
61. Sacks DL, Kenney RT, Kreutzer RD, Jaffe CL, Gupta AK, Shanna MC, et al Indian kala-azar caused by Leishmania tropica. Lancet 1995;345:959-61.
62. Chatterjee M, Manna M, Bhaduri AN, Sarkar D. Recent kala-azar cases in India: Isoenzyme profile of Leishmania parasites. Indian J Med Res 1995;102:165-72.
63. Magill AJ, Grogl M, Gasser RA Jr, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993;328: 1383-7.
64. Schnur LF. On the clinical manifestations and parasites of old world leishmaniasis and Leishmania tropica causing visceral leishmaniasis. In: Hart DT (ed). Leishmaniasis, the current status and new strategies for control. NATO ASI Series No. A163. New York and London:Platinum Press, 1987:939-43.
65. Oren R, Schnur LF, Ben Yehuda D, Mayner V, Okon E, Rachmilewitz EA. Visceral leishmaniasis: A difficult diagnosis and unusual causative agent. J Infect Dis 1991; 164:746-9.
66. Mandanti F, Sozzi S. Isolation of Leishmania from a newborn puppy. Trans R Soc Trop Med Hyg 1995;89:402.
67. Mishra M, Singh MP, Choudhury D, Singh VP, Khan AB. Amphotericin B for second-line treatment of Indian kala-azar. Lancet 1991;337:926.
68. Giri OP. Amphotericin B in visceral leishmaniasis. Indian Pediatr 1993;30:74-8.
69. Mishra M, Biswas UK, Jha DN, Khan AB. Amphotericin versus pentamidine in antimony unresponsive kala-azar. Lancet 1992;340:1256-7.
70. Thakur CP, Sinha GP, Pandey AK, Barat D, Sinha PK. Amphotericin B in resistant kala-azar in Bihar. Natl Med J India 1993;6:57-60.
71. Singh MP, Mishra M, Khan AB, Ramdas SL, Panjiyar S. Gold treatment for kala-azar. BMJ 1989;299:1318.
72. Chatterjee S, Chatterjee R. Visceral leishmaniasis treated with rifampicin and cotrimoxazole. Indian Pediatr 1993;30:716-18.
73. Thakur CP, Kumar M. Observation on the effect of verapamil with sodium stibogluconate in kala-azar. Trop Geograph Med 1992;44:15-18.
74. Thakur CP, Olliaro P, Gothoskar S, Bhowmick S, Choudhury BK, Prasad S, et al. Treatment of visceral leishmaniasis (kala-azar) with aminosidine (paramonycin)-antimonial (combination), a pilot study in Bihar, India. Trans R Soc Trop Med Hyg 1992;86:615-16.
75. Sundar S, Rosenkaimer F, Murray HW. Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamraa. J Infect Dis 1994;170:659-62.
76. Iwu MM, Jackson JE, Schuster BG. Medicinal plants in the fight against leishmaniasis. Parasitol Today 1994;10:65-8.
77. Kapil A, Sharma S, Wahidulla S. Leishmanicidal activity of 2-benzoxazolinone from Acanthus illicifolius in vitro. Planta Med 1994;60:187-8.
78. Modabber F. Vaccine: The only hope to control leishmaniasis. In: Tapia FJ, Caceres-Dittmar G, Sanchex MAJ (eds). Molecular and immune mechanisms in the pathogenesls of cutaneous leishmaniasis. Tropical Disease Research Progress 1995-96. Thirteenth Programme Report. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Disease (TDR). World Health Organization, Geneva.
79. Dye C. The logic of visceral leishmaniasis control. Am J Trop Med Hyg 1996;55: 125-30.
80. Anuradha, Pal R, Zehra K, Katiyar JC, Sethi N, Bhatia G, et al. The Indian langur: Preliminary report of a new nonhuman primate host for visceral leishmaniasis. Bull World Health Organ 1992;70:63-72.
81. Kalra SP, Bahl A, Sanchetee PC, Dham SK. Management of kala-azar - An update. Med J Armed Forces India 1996;52:189-92.